ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome

NCT05116761 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study no longer part of development plan.

Conditions

Covid19
Postviral Syndrome
Dyspnea

Interventions

BIOLOGICAL: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles
OTHER: Saline

Sponsor

Direct Biologics, LLC